Podcasts
Listen to the latest oncology news from international experts
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Updates in EGFR-mutant NSCLC
A large proportion of patients with non-small cell lung cancer (NSCLC) have mutations in EGFR, making it a popular target for novel therapeutics. In this podcast, we hear from Prof. Charles Swanton, Dr Emilia Lim, Prof. Sanjay Popat, Dr Qing Zhou, Dr Hazel O’Sullivan, Dr Julia Rotow, and Dr Biagio Ricciuti, as they discuss some of the latest clinical trial data in this field, as well as perspectives on molecular testing and new research into the causes of EGFR-mutant lung cancer.
Date: 2nd December 2022
